Semler Scientific, Inc. (SMLR)
USD 34.06
(-8.02%)
USD 34.06
(-8.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 38.94 Million USD | 10.54% |
| 2022 | 35.23 Million USD | 28.3% |
| 2021 | 27.46 Million USD | 42.38% |
| 2020 | 19.28 Million USD | 4.83% |
| 2019 | 18.39 Million USD | 36.83% |
| 2018 | 13.44 Million USD | 25.06% |
| 2017 | 10.75 Million USD | 39.27% |
| 2016 | 7.72 Million USD | -38.6% |
| 2015 | 12.57 Million USD | 72.61% |
| 2014 | 7.28 Million USD | 85.39% |
| 2013 | 3.92 Million USD | 20.89% |
| 2012 | 3.25 Million USD | 66.67% |
| 2011 | 1.95 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.68 Million USD | -16.07% |
| 2024 Q3 | 7.29 Million USD | -7.24% |
| 2024 Q2 | 7.86 Million USD | 2.34% |
| 2023 Q2 | 10.2 Million USD | -4.45% |
| 2023 Q1 | 10.68 Million USD | 18.73% |
| 2023 FY | 38.94 Million USD | 10.54% |
| 2023 Q4 | 9.15 Million USD | 2.74% |
| 2023 Q3 | 8.9 Million USD | -12.74% |
| 2022 Q3 | 8.44 Million USD | -2.82% |
| 2022 Q4 | 8.99 Million USD | 6.56% |
| 2022 Q1 | 9.1 Million USD | 18.74% |
| 2022 FY | 35.23 Million USD | 28.3% |
| 2022 Q2 | 8.68 Million USD | -4.58% |
| 2021 Q1 | 5.58 Million USD | 9.68% |
| 2021 Q4 | 7.66 Million USD | 4.23% |
| 2021 Q2 | 6.85 Million USD | 22.67% |
| 2021 FY | 27.46 Million USD | 42.38% |
| 2021 Q3 | 7.35 Million USD | 7.37% |
| 2020 Q1 | 5.12 Million USD | -1.33% |
| 2020 Q2 | 4.71 Million USD | -8.09% |
| 2020 Q4 | 5.09 Million USD | 17.0% |
| 2020 FY | 19.28 Million USD | 4.83% |
| 2020 Q3 | 4.35 Million USD | -7.66% |
| 2019 Q3 | 4.81 Million USD | 10.15% |
| 2019 Q2 | 4.37 Million USD | 9.03% |
| 2019 Q4 | 5.19 Million USD | 7.89% |
| 2019 Q1 | 4.01 Million USD | 5.19% |
| 2019 FY | 18.39 Million USD | 36.83% |
| 2018 FY | 13.44 Million USD | 25.06% |
| 2018 Q4 | 3.81 Million USD | 11.56% |
| 2018 Q3 | 3.41 Million USD | 4.56% |
| 2018 Q2 | 3.26 Million USD | 10.96% |
| 2018 Q1 | 2.94 Million USD | -6.15% |
| 2017 Q1 | 2.26 Million USD | 19.59% |
| 2017 Q2 | 2.54 Million USD | 12.14% |
| 2017 Q3 | 2.8 Million USD | 10.51% |
| 2017 Q4 | 3.13 Million USD | 11.83% |
| 2017 FY | 10.75 Million USD | 39.27% |
| 2016 Q1 | 2.01 Million USD | -61.08% |
| 2016 FY | 7.72 Million USD | -38.6% |
| 2016 Q4 | 1.89 Million USD | 2.99% |
| 2016 Q3 | 1.83 Million USD | -6.79% |
| 2016 Q2 | 1.97 Million USD | -2.13% |
| 2015 Q4 | 5.18 Million USD | 89.81% |
| 2015 Q3 | 2.72 Million USD | 15.05% |
| 2015 FY | 12.57 Million USD | 72.61% |
| 2015 Q2 | 2.37 Million USD | 1.8% |
| 2015 Q1 | 2.33 Million USD | 14.05% |
| 2014 Q1 | 1.47 Million USD | 30.04% |
| 2014 Q3 | 2.08 Million USD | 23.95% |
| 2014 Q4 | 2.04 Million USD | -2.06% |
| 2014 FY | 7.28 Million USD | 85.39% |
| 2014 Q2 | 1.68 Million USD | 14.33% |
| 2013 Q4 | 1.13 Million USD | 18.78% |
| 2013 Q1 | 885 Thousand USD | 22.41% |
| 2013 FY | 3.92 Million USD | 20.89% |
| 2013 Q2 | 996 Thousand USD | 12.54% |
| 2013 Q3 | 953 Thousand USD | -4.32% |
| 2012 Q3 | 891 Thousand USD | 0.0% |
| 2012 Q4 | 723 Thousand USD | -18.86% |
| 2012 FY | 3.25 Million USD | 66.67% |
| 2011 FY | 1.95 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -246.971% |
| Cerus Corporation | 143.15 Million USD | 72.796% |
| OrthoPediatrics Corp. | 137.01 Million USD | 71.578% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -242.791% |
| Talis Biomedical Corporation | 67.18 Million USD | 42.036% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -56.113% |
| Inogen, Inc. | 236.08 Million USD | 83.504% |
| Spectral AI, Inc. | 20.86 Million USD | -86.656% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 30.453% |
| CVRx, Inc. | 76.14 Million USD | 48.853% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1003.856% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -211.826% |
| Orthofix Medical Inc. | 667.42 Million USD | 94.165% |
| Venus Concept Inc. | 80.47 Million USD | 51.608% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 31.168% |
| Bioventus Inc. | 409.91 Million USD | 90.5% |
| BrainsWay Ltd. | 28.01 Million USD | -38.996% |
| Envoy Medical, Inc. | 17.89 Million USD | -117.589% |
| electroCore, Inc. | 32.03 Million USD | -21.582% |
| IceCure Medical Ltd | 16.87 Million USD | -130.766% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 8.22% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -120.858% |
| MaxCyte, Inc. | 84.84 Million USD | 54.1% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -213.767% |
| Nexalin Technology, Inc. | 5.78 Million USD | -573.614% |
| PAVmed Inc | 64.82 Million USD | 39.926% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 23.756% |
| RxSight, Inc. | 103.85 Million USD | 62.5% |
| Sight Sciences, Inc. | 126.44 Million USD | 69.202% |
| SI-BONE, Inc. | 156.35 Million USD | 75.092% |
| TELA Bio, Inc. | 84.18 Million USD | 53.741% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 44.41% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 80.85% |
| LivaNova PLC | 843.54 Million USD | 95.383% |
| 908 Devices Inc. | 68.08 Million USD | 42.797% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 91.947% |
| Nemaura Medical Inc. | 7.13 Million USD | -445.526% |
| NeuroPace, Inc. | 75.29 Million USD | 48.279% |
| LENSAR, Inc. | 33.33 Million USD | -16.823% |
| Apyx Medical Corporation | 51.01 Million USD | 23.666% |
| Cutera, Inc. | 197.72 Million USD | 80.304% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -57.153% |
| BioSig Technologies, Inc. | 28.53 Million USD | -36.502% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 79.661% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -7.998% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 95.344% |
| Axonics, Inc. | 270.2 Million USD | 85.587% |
| Outset Medical, Inc. | 198.77 Million USD | 80.408% |
| IRIDEX Corporation | 31.81 Million USD | -22.412% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 78.391% |
| IRadimed Corporation | 30.12 Million USD | -29.284% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -356.446% |
| INVO Bioscience, Inc. | 7.85 Million USD | -395.894% |
| Telesis Bio, Inc. | 63.48 Million USD | 38.66% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 60.444% |
| Varex Imaging Corporation | 224.8 Million USD | 82.676% |
| Quipt Home Medical Corp. | 148.66 Million USD | 73.805% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -232.202% |
| Pulmonx Corporation | 112.68 Million USD | 65.441% |
| Dynatronics Corporation | 9.9 Million USD | -293.055% |
| Modular Medical, Inc. | 17.52 Million USD | -122.169% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -92.916% |
| InMode Ltd. | 215.68 Million USD | 81.944% |
| Bruker Corporation | 1.07 Billion USD | 96.382% |
| Cytosorbents Corporation | 48.33 Million USD | 19.432% |
| DexCom, Inc. | 1.69 Billion USD | 97.697% |
| Align Technology, Inc. | 2.07 Billion USD | 98.125% |
| Viveve Medical, Inc. | 22.17 Million USD | -75.637% |
| ZimVie Inc. | 275.12 Million USD | 85.845% |
| Movano Inc. | 29.69 Million USD | -31.169% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 71.63% |
| Nexalin Technology, Inc. | 5.78 Million USD | -573.614% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1003.856% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 93.519% |
| Profound Medical Corp. | 33.6 Million USD | -15.894% |
| Insulet Corporation | 939.9 Million USD | 95.857% |
| enVVeno Medical Corporation | 25.23 Million USD | -54.307% |
| Surmodics, Inc. | 98.69 Million USD | 60.542% |
| iCAD, Inc. | 22.22 Million USD | -75.226% |
| Nuwellis, Inc. | 22.61 Million USD | -72.22% |
| Biotricity, Inc. | 17.18 Million USD | -126.622% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 91.266% |
| Aethlon Medical, Inc. | 12.27 Million USD | -217.198% |
| InspireMD, Inc. | 22.95 Million USD | -69.691% |
| PAVmed Inc. | 64.82 Million USD | 39.926% |
| BIOLASE, Inc. | 34.66 Million USD | -12.357% |
| Beyond Air, Inc. | 61.7 Million USD | 36.882% |
| FONAR Corporation | 28.6 Million USD | -36.146% |
| AxoGen, Inc. | 149.33 Million USD | 73.922% |
| Vivani Medical, Inc. | 26.96 Million USD | -44.424% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 78.009% |
| Inari Medical, Inc. | 448.59 Million USD | 91.319% |
| UFP Technologies, Inc. | 58.08 Million USD | 32.958% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -690.324% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -516.369% |
| Tenon Medical, Inc. | 16.96 Million USD | -129.514% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -426.769% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 11.697% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.387% |
| Sintx Technologies, Inc. | 15.2 Million USD | -156.194% |
| NanoVibronix, Inc. | 4.97 Million USD | -683.109% |
| Quanterix Corporation | 118.1 Million USD | 67.025% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -232.202% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -169.658% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 90.082% |
| TransMedics Group, Inc. | 182.82 Million USD | 78.698% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -38.764% |
| NeuroMetrix, Inc. | 11.09 Million USD | -250.881% |
| Hyperfine, Inc. | 52.87 Million USD | 26.343% |
| Establishment Labs Holdings Inc. | 172 Million USD | 77.359% |
| Biomerica, Inc. | 6.97 Million USD | -458.097% |
| Bone Biologics Corporation | 9.42 Million USD | -313.054% |
| AVITA Medical, Inc. | 80.77 Million USD | 51.79% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -277.686% |
| Silk Road Medical, Inc | 186.35 Million USD | 79.102% |